Role of the Receptor for Advanced Glycation End Products (RAGE) in Blood As a Potential Biomarker for Progression to Olaparib: A Post Hoc Analysis of Patients with Platinum-Resistant Ovarian Cancer (PROC) Treated in the ROLANDO-GEICO 1601 Trial.
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined